This collaboration is in addition to Biocon Biologics’ own insulin aspart drug product for the US, which is currently under ...
Alfred L. Garfall, MD, discusses the phase 2 BMT CTN 1902 trial of idecabtagene vicleucel in patients with multiple myeloma.
Cite this: What's Next? Clinical Trials in Myelofibrosis - Medscape - Mar 06, 2025.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback